Design, Synthesis and Anticancer Evaluation of Chalcone-thiazolidinone Hybrids
Abstract
Abstract
A small series of chalcone-thiazolidinone hybrids has been designed, synthesized in good yield and evaluated for anticancer activity on the three cell lines A-549, U-87 and COLO-205. All the compounds showed significant cytotoxic effect in micromolar range on the three cell lines. Compounds CT8 and CT6 were found to be the most potent on A-549 and COLO-205 (IC50 = 38.89 µM and 52.23 µM), respectively.
Keywords: Chalcone-thiazolidinone, cytotoxic, anticancer activity
Cite this Article
Kumar A, Goyal R, Kumar S. Design, Synthesis and Anticancer Evaluation of Chalcone-thiazolidinone Hybrids. Research & Reviews: A Journal of Drug Design & Discovery. 2016; 3(2): 23–30p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
